Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 147 | 141 | 163 | 76 | 268 |
| Accounts receivable | -3,357 | 1,359 | 1,090 | -124 | 297 |
| Accounts payable and accrued liabilities | -207 | 245 | 300 | 653 | 670 |
| Other Working Capital | -3,452 | 366 | 1,250 | -766 | 2,003 |
| Other Operating Activity | -2,745 | -15,855 | -11,086 | -5,481 | -9,601 |
| Operating Cash Flow | $-9,614 | $-13,744 | $-8,283 | $-5,642 | $-6,363 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -290 | -523 | -665 |
| Common Stock Issued | 0 | 0 | 0 | 39,168 | 0 |
| Other Financing Activity | 0 | 0 | 0 | -2,992 | 0 |
| Financing Cash Flow | $0 | $0 | $-290 | $35,653 | $-665 |
| Exchange Rate Effect | -755 | 2,506 | 94 | -2,222 | 72 |
| Beginning Cash Position | 35,195 | 46,433 | 54,912 | 27,123 | 34,079 |
| End Cash Position | 24,826 | 35,195 | 46,433 | 54,912 | 27,123 |
| Net Cash Flow | $-9,614 | $-13,744 | $-8,573 | $30,011 | $-7,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,614 | -13,744 | -8,283 | -5,642 | -6,363 |
| Free Cash Flow | -9,614 | -13,744 | -8,283 | -5,642 | -6,363 |